期刊文献+

IFN-α 2b对人脉络膜黑色素瘤细胞的毒性作用及对端粒酶活性的影响

Effects of IFN-α 2b on telomerase activity and the toxic effects to cultured choroidal melanoma of human eyes
下载PDF
导出
摘要 目的:研究干扰素(IFN-α2b)对人眼脉络膜黑色素瘤细胞端粒酶活性的影响及其对细胞的毒性作用,为临床化疗提供更多依据。方法:采用原代培养的人眼脉络膜黑色素瘤细胞做实验材料,用不同浓度IFN-α2b、作用不同时间,设立对照组,用MTT法检测IFN-α2b对细胞的毒性作用,PCR-ELISA法测定细胞中端粒酶活性的变化,并对两者关系进行相关分析。结果:随着IFN-α2b浓度及作用时间的增加,细胞中端粒酶活性逐渐下降,在药物浓度大于5×104IU/L及作用时间达到24 h后,其活性出现大幅度下降,随后出现细胞抑制率的明显升高,与端粒酶活性的下降具有一定的相关性。但均发生不同程度的滞后现象。结论:IFN-α2b可作为一种端粒酶抑制剂,有效降低体外培养的人眼脉络膜黑色素瘤细胞的端粒酶活性,呈浓度和时间依赖性,并造成细胞死亡。 AIM: To study the effects of interferon-α 2b ( IFN-α 2b) on the telomerase activity of choroidal melanoma cells of human eyes and the toxic effects to the cells. METHODS : IFN-α 2b was used with different concentrations and times to act on the primary cultured choroidal melanoma cells of human eyes. The toxic effects were evaluated by MTT assay and the levels of telomera activity were detected by PCR - ELISA assay. A correlation between the two results was analyzed. RESULTS: The telomerase activity gradually decreased following the increasing concentrations and times of treatment with IFN -α 2b, which accompany the step - up of restrain rate of the cells. At the point when the concentration attained 5 × 10^4 IU/L or the time attained 24 h, the telomerase activity decreased very obviously. However, the appearance of cell death lagged behind the decreasing of telomerase. CONCLUSION: IFN -α 2b is an effective telomerase inhibitor, which can decrease the telomerase activity in choroidal melanoma cells of human eyes effectively. The IFN-α 2b treatment is concentration and time dependent, and can cause the death of cultured cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第1期123-127,共5页 Chinese Journal of Pathophysiology
基金 广东省科技计划项目(No.2006B36006011No.2008B030301253) 广东省自然科学基金资助项目(No.04300319)
关键词 干扰素Α 脉络膜黑色素瘤 端粒 末端转移酶 Interferon - alpha Choroidal melanoma Telomerase
  • 相关文献

参考文献10

  • 1Heine B, Coupland SE, Kneiff S. Telomerase expression in uveal melanoma[J]. Br J Ophthalmol, 2000, 84(2) : 217 - 223.
  • 2Rohrbach JM, Riedinger C, Wild M. Telomerase activity in uveal melanomas[J]. Ophthalmologe, 2000, 97(5) : 359 -363.
  • 3钱劼靖,金洁.干扰素-α联合高三尖杉酯碱下调K562细胞端粒酶逆转录酶及端粒酶活性诱导细胞凋亡[J].中国病理生理杂志,2006,22(9):1747-1750. 被引量:6
  • 4Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter[J]. Hum Mol Genet, 1999,8 ( 1 ) : 137 - 142.
  • 5Wang J, Xie LY, Allan S, et al. Myc activates telomerase [J]. Gene Dev, 1998,12(12) :1769 - 1774.
  • 6Akiyama M, Iwase S, Horiguchi - Yamada J, et al. Interferon - alpha repressed telomerase along with G1 - accumulation of Daudi cells[J]. Cancer Lett, 1999,142(1) :23 -30.
  • 7孟志强,吴红梅,陈震,黄雯霞,宋明志.干扰素对肝癌细胞端粒酶活性及c-myc蛋白的影响[J].上海医学,2001,24(3):137-139. 被引量:3
  • 8Horikawa I, Cable PL, Mshari C, et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene [ J ]. Cancer Res, 1999,59 (4) : 826 - 830.
  • 9Greenberg RA, O' Hagan RC, Deng H, et al. Telornerase reverse transcriptase gene is a direct target of c - Myc but is not functionally equivalent in cellular transformation [ J ]. Oncogene, 1999,18 ( 5 ) : 1219 - 1226.
  • 10Wu K J, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c - myc [ J ]. Nat Genet, 1999,21 (2) :220 -224.

二级参考文献11

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部